Literature DB >> 9798769

Successful outcome in Swan-Ganz catheter-induced rupture of pulmonary artery.

E D Stancofski1, A Sardi, G L Conaway.   

Abstract

Swan-Ganz catheter-induced pulmonary artery (PA) rupture is rare, with an incidence of 0.016 to 0.2 per cent, but it remains the most dreaded complication in the placement of these catheters with a mortality above 50 per cent. We report two cases of PA rupture after catheter placement. Both patients were managed nonoperatively and without any invasive procedure. They both stopped bleeding after the initial episode and were discharged a few days later. We believe that in the absence of high-risk factors, such as pulmonary hypertension and systemic anticoagulation, PA rupture from a Swan-Ganz catheter can be successfully treated by withdrawal of the catheter and supportive care.

Entities:  

Mesh:

Year:  1998        PMID: 9798769

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Management of a case of endobronchial blood clot in the post operative period.

Authors:  Jyotirmoy Das; Saurabh Mahajan; Mukesh Kumar Samplay; Naresh Kumar Aggarwal
Journal:  Indian J Anaesth       Date:  2009-04

2.  Endovascular treatment of PA pseudoaneurysm caused by Swan-Ganz catheter.

Authors:  Piotr N Rudziński; Marcin Demkow; Ilona Michałowska; Elżbieta Abramczuk; Piotr Szymański
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-03-23       Impact factor: 1.426

3.  Pulmonary artery rupture as a complication of Swan-Ganz catheter application. Diagnosis and endovascular treatment: a single centre's experience.

Authors:  Piotr N Rudziński; Jan Henzel; Zofia Dzielińska; Barbara M Lubiszewska; Ilona Michałowska; Piotr Szymański; Radosław Pracoń; Tomasz Hryniewiecki; Marcin Demkow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-05-11       Impact factor: 1.426

Review 4.  Optimization of the target strategy of perioperative infusion therapy based on monitoring data of central hemodynamics in order to prevent complications.

Authors:  Dmytro Dmytriiev; Oleksandr Nazarchuk; Mykola Melnychenko; Bohdan Levchenko
Journal:  Front Med (Lausanne)       Date:  2022-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.